This page uses content from Wikipedia and is licensed under CC BY-SA.
|Chemical and physical data|
|Molar mass||416.753 g/mol|
|3D model (JSmol)|
|(what is this?)|
S-23 is an investigational selective androgen receptor modulator (SARM) developed by GTX, Inc as a potential male hormonal contraceptive. It binds to the androgen receptor more strongly than older drugs such as andarine with a Ki of 1.7 nM, and in animal studies it showed both a good ratio of anabolic to androgenic effects, and dose-dependent suppression of spermatogenesis with spontaneous recovery after cessation of treatment.
|This drug article relating to the genito-urinary system is a stub. You can help Wikipedia by expanding it.|